Table 1.

Baseline characteristics of study participants of full analysis set group

n	40
Age (years)	64.0 ± 9.4
Sex (men/women)	26/14
Duration of diabetes (years)	11.8 ± 8.2
Height (cm)	163.5 ± 8.7
Body weight, kg (n = 38)	67.6 ± 12.7
Body mass index, kg/m2 (n = 38)	25.0 ± 3.9
Smoking (never/past/current smoker)	20/14/6
Alcohol consumption (no/yes)	21/19
Retinopathy, no/yes (n = 35)	29/6
Nephropathy, normo/micro/macroalbuminuria (n = 39)	23/13/3
Metformin dosage (mg)	875 ± 392
Sulfonylurea (no/yes)	30/10
Thiazolidine (no/yes)	40/0
α‐Glucosidase inhibitor (no/yes)	37/3
Dipeptidyl peptidase‐4 inhibitor (no/yes)	16/24
Sodium glucose cotransporter‐2 inhibitor (no/yes)	25/15
Insulin (no/yes)	36/4
Antihypertension medication (no/yes)	21/19
Dyslipidemia medication (no/yes)	26/14